Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Genomic Revolution ETF (ARKG) vs Under Armour Inc Class A (UAA) Price & Performance

ARK Genomic Revolution ETF
Under Armour Inc Class A

Price performance

Price movement over the last 24 hours

Key statistics

ARK Genomic Revolution ETF vs Under Armour Inc Class A — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Under Armour Inc Class A trades at $6.72 (market cap $2.86B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals.

ARKGUAA
Sector
Sector/ThematicConsumer Cyclical
52-Week High
$43.57$8.14
52-Week Low
$23.09$4.17
Market Cap
$2.86B
Enterprise Value
$4.49B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Genomic Revolution ETF

ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.

The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.

Under Armour Inc Class A

Under Armour (UAA) trades at $6.79, up 3.03% today, showing technical bullish momentum with moving averages supporting upward movement. However, the company faces fundamental challenges with negative net income margins (-9.98%) and declining revenue from $5.7B in 2024 to $5.2B in 2025. Recent earnings showed mixed results with a Q1 2026 miss, while cash flow remains negative at -$362M for 2025. The Dodge collaboration and Persona AI partnership represent strategic initiatives amid ongoing North American market weakness.

The outlook remains cautious with analyst consensus price target at $5.96 below current levels, reflecting concerns about profitability and revenue trends. Investment opportunity exists if international growth and cost management improve margins, but risks include persistent North American weakness, margin pressure, and negative cash flow generation. Wall Street sentiment leans neutral with 58% hold ratings.

Returns comparison

Trailing returns across standard periods

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.

Read more on ARKG

About Under Armour Inc Class A

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.

Read more on UAA